| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234016 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
Boosting a partial volume of the prostate with hypofractionated HDR-BT for aggressive prostate cancer was feasible and showed limited long-term toxicity, which compared favorably with other dose-escalation methods in the literature. Preliminary bDFS was encouraging if one considers the negatively selected population of high-risk patients in this study.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Carmen M.D., Youri M.D., Sandro S.D., Philippe D.Sc., Giovanna D.Sc., Sabine M.D., Orhan M.D., Michel D.Sc., Haleem M.D., Raymond M.D.,